Navigation Links
West to Present at the Ninth Annual CJS Securities 'New Ideas' Summer Conference
Date:8/11/2009

LIONVILLE, Pa., Aug. 11 /PRNewswire-FirstCall/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that William Federici, Chief Financial Officer, and Michael Anderson, Vice President, Treasurer and Head of Investor Relations, will be attending the Ninth Annual CJS Securities "New Ideas" Summer Conference on Tuesday, August 18, 2009 in White Plains, NY.

While there will be no formal presentation or a webcast, Mr. Federici and Mr. Anderson will present a brief summary on the Company's business as well as provide a business outlook and take questions from the conference attendees.

About West

West is a global manufacturer of components and systems for injectable drug delivery, including stoppers and seals for vials, and closures and disposable components used in syringe, IV and blood collection systems. The Company also provides products with application to the personal care, food and beverage markets. Headquartered in Lionville, Pennsylvania, West supports its partners and customers from 50 locations throughout North America, South America, Europe, Mexico, Japan, Asia and Australia. For more information, visit West at www.westpharma.com.

    Contacts:
    West Pharmaceutical Services, Inc.
    Michael A. Anderson
    Vice President and Treasurer
    (610) 594-3345

    Investors and Financial Media:
    FD
    Evan Smith / Matthew Duch
    (212) 850-5600
    wst@fd.com



'/>"/>
SOURCE West Pharmaceutical Services, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. HeartWare to Present at Canaccord Adams 29th Annual Global Growth Conference
2. ResMed Inc. to Present at Upcoming Investor Conferences
3. NBTY to Web Cast Presentation at Canaccord Adams Global Growth Conference; Announces Preliminary Unaudited Net Sales Results for July 2009
4. WebMD to Present at the Canaccord Adams 29th Annual Global Growth Conference
5. Courage Center Presents 2009 National Courage Award to Jordan Thomas
6. Insulet Corporation to Present at Upcoming Investor Conferences
7. Transition Therapeutics to Present at Canaccord Adams 29th Annual Global Growth Conference
8. Inverness Medical Innovations to Present at the Canaccord Adams Global Growth Conference on August 11, 2009
9. Osteotech to Present at the Canaccord Adams 29th Annual Global Growth Conference
10. Cyberonics to Present at Canaccord Adams 29th Annual Global Growth Conference
11. Cryo-Cell to Present Novel Adult Stem Cell Research During 2009 China Medical Biotech Forum
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... ... December 05, 2016 , ... Sabah Shah MD, MBA has joined the Retina ... of New York was founded by James M. Maisel, MD and has been providing tertiary ... has always followed a legacy of surpassing expectations amongst her peers. Growing up in ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... Surgical Facial Rejuvenation" at the 2016 Anti-Aging & Beauty Awards at The ... The Aesthetic & Anti-aging Medicine European Congress (AMEC) brings together the industry’s ...
(Date:12/4/2016)... ... December 03, 2016 , ... The Lymphoma Research Foundation (LRF) ... and serving the lymphoma community through a comprehensive series of education programs, outreach ... in New York City, with long-time partners The Paul Foundation, on November 10, ...
(Date:12/4/2016)... ... 03, 2016 , ... Penrose Senior Care Auditors® was announced ... evening at the 26th Annual SMU Cox Dallas 100™ Awards Ceremony and Banquet ... for Entrepreneurship. Dallas 100™, co-founded by the Caruth Institute, honors the ingenuity, commitment ...
(Date:12/4/2016)... ... December 04, 2016 , ... Responsible dental care hinges on regular brushing of ... optimal results. This important necessity inspired an inventor from Las Vegas, Nev., to design ... that people break or avoid bad techniques of brushing the teeth in order to ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... Israel , December 5, 2016 ... identifying, in-licensing and developing promising therapeutic candidates, presents positive Phase ... BL-8040, the Company,s leading oncology platform at the ongoing 58th ... San Diego, California . ... , , ...
(Date:12/5/2016)... Taiwan , Dec. 5, 2016 ... non-inferiority to hydroxyurea (HU) in Complete Hematologic Response (CHR) ... profile of ropeginterferon alfa-2b versus HU AOP ... follow-up trial CONTINUATION-PV to obtain European marketing authorization in the ... data to the FDA as it seeks approval for commercialization ...
(Date:12/4/2016)... --  Pairnomix, LLC, a genetic research company and member ... White House, today announced that findings from its first case ... therapies for a patient with epileptic encephalopathy caused by a ... the 70 th Annual Meeting of the American ... December 2-6, 2016.  Pairnomix, unique process involves creating ...
Breaking Medicine Technology: